Newsroom
Sorted by: Latest
-
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Monday 11 May 2026, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris (France). The...
-
Sensorion annonce la mise à disposition des documents préparatoires à l’Assemblée Générale mixte du 11 mai 2026
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société biotechnologique pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir les pertes d'audition, annonce aujourd'hui que les actionnaires de la Société sont invités à participer à l’Assemblée Générale mixte qui se tiendra le lundi 11 mai 2026 à 14h00 CET, dans les locaux de l’hôtel Square Louvois, situé 12, rue de Louvois, 75002 Paris (France)....
-
SynSmart und Amporin geben Zusammenarbeit zur Entwicklung bahnbrechender niedermolekularer Therapeutika für degenerative Erkrankungen bekannt
MUMBAI, Indien & BASEL, Schweiz--(BUSINESS WIRE)--SynSmart Rasayan Research Private Limited und Amporin Pharmaceuticals AG gaben heute eine Zusammenarbeit zur Entwicklung bahnbrechender niedermolekularer Therapeutika zur Behandlung tödlicher degenerativer Erkrankungen bekannt. Im Rahmen dieser Zusammenarbeit wird SynSmart in seiner Forschungseinrichtung in Mumbai eine umfangreiche Bibliothek neuartiger membranprotektiver Moleküle synthetisieren. Nach dem Screening könnte die Zusammenarbeit auf...
-
SynSmart et Amporin annoncent une collaboration pour développer une thérapie révolutionnaire par petites molécules pour les maladies dégénératives
BOMBAY, Inde et BÂLE, Suisse--(BUSINESS WIRE)--SynSmart Rasayan Research Private Limited et Amporin Pharmaceuticals AG annoncent aujourd'hui une collaboration visant à développer des thérapies révolutionnaires à base de petites molécules pour le traitement de maladies dégénératives mortelles. Dans le cadre de cette collaboration, SynSmart synthétisera une vaste bibliothèque de nouvelles molécules de protection membranaire dans son centre de recherche à Bombay. La collaboration pourrait être éte...
-
H2O.ai Showcases Safe, Secure, and Responsible AI Innovation for Government at Australian Government Data Summit 2026
SYDNEY--(BUSINESS WIRE)--H2O.ai, a global leader in enterprise Agentic AI for on-premise, air-gapped, and sovereign deployments, today announced its participation in the Australian Government Data Summit — underscoring its commitment to delivering safe, sovereign, and responsible AI for government and regulated industries. As public sector organisations accelerate digital transformation while navigating increasingly complex data sovereignty and compliance requirements, H2O.ai is addressing a cr...
-
NEURA Robotics and Amazon Web Services Enter Strategic Collaboration to Accelerate Physical AI at Scale
METZINGEN, Germany--(BUSINESS WIRE)--NEURA Robotics (NEURA) and Amazon Web Services (AWS) today announced a strategic agreement to accelerate Physical AI at scale – bringing cognitive robots that can perceive, reason, and act alongside humans from development into global deployment. The collaboration combines NEURA's cognitive robotics platform with AWS's cloud and AI infrastructure to help train, validate, and deploy the next generation of intelligent robots. The collaboration tackles one of t...
-
OMRON and Dassault Systèmes Partner to Revolutionize Manufacturing with Virtual and Real Integration
VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and OMRON (TSE:6645), a global leader in industrial automation technologies, today announced their partnership to bridge the gap between information technology (IT) and operational technology (OT). This collaboration enables manufacturers and machine builders to design, simulate, and deploy smarter, more flexible, and higher-performing production systems through a unified approach that merges...
-
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Gazyva® (obinutuzumab) for the treatment of systemic lupus erythematosus (SLE). The filing acceptance is based on positive results from the Phase III ALLEGORY study, which demonstrated a statistically significant and clinically meaningful b...
-
Barnes Molding Solutions Becomes SPECTRIX
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Barnes Molding Solutions is now SPECTRIX. The new Brand offers the full Spectrum of injection molding capabilities delivered by its leading brands - Männer, Foboha, Synventive, Priamus, Thermoplay, and Gammaflux. The change, announced at Chinaplas 2026, reflects the integration of core technologies within a single organization: part design, material science, hot runner and mold technology, sensors & controls and injection molding. Day-to-day operations r...
-
RIIG Technology, Inc. (dba HOOTL™) Announces Successful Close of $6M+ Million Series A to Accelerate AI-Driven Healthcare and Infrastructure Solutions
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--RIIG Technology, Inc, doing business as HOOTL™ (Humans Out of the Loop™), announces the successful close of its $6M+ Series A financing round....